Psychological and pharmacological approaches to treating insomnia: Critical issues in assessing their separate and combined effects

Clinical Psychology Review

Volumn 16, Issue 6, 1996, Pages 521-542

  Morin, Charles M ^a   Wooten, Virgil ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORAL HYDRATE; HYPNOTIC SEDATIVE AGENT; SEDATIVE AGENT;

BEHAVIOR THERAPY; COGNITIVE THERAPY; HUMAN; INSOMNIA; PSYCHOTHERAPY; REVIEW; TREATMENT PLANNING;

EID: 0029948281     PISSN: 02727358     EISSN: None     Source Type: Journal    
DOI: 10.1016/0272-7358(96)00027-X     Document Type: Article

References (120)

1. Allgulander, C., Borg S., & Vikander, B. (1984). A 4-6-year follow-up of 50 patients with primary dependence on sedative and hypnotic drugs. American Journal of Psychiatry, 141, 1580-1582.
2. American Psychiatric Association. (1990). Benzodiazepine dependence, toxicity, and abuse: A task force report of the American Psychiatric Association. Washington, DC: Author.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Balter, M. B., & Uhlenhuth, E. H. (1991). The beneficial and adverse effects of hypnotics. Journal of Clinical Psychiatry, 52, 16-23.
5. Balter, M. B., & Uhlenhuth, E. H. (1992). New epidemiologic findings about insomnia and its treatment. Journal of Clinical Psychiatry, 53(Suppl 12), 34-39.
6. Becker, P. M., Brown, W. D., & Jamieson, A. O. (1991). Impact of insomnia: Assessment with the sickness impact profile. Sleep Research, 20, 206.
7. Bootzin, R. R., Epstein, D., & Wood, J. M. (1991). Stimulus control instructions. In P. Hauri (Ed.), Case studies in insomnia (pp. 19-28). New York: Plenum Press.
8. Buysse, D. J., Reynolds, C. F., Kupfer, D. J., Thorpy, M. J., Bixler, E., Manfredi, R., Kales, A., Vgontzas, A., Stepanski, E., Roth, T., Hauri, P., & Mesiano, D. (1994). Clinical diagnoses in 216 insomnia patients using the international classification of sleep disorders (ICSD), DSM-IV and ICD-10 categories: A report from the APA/NIMH DSM-IV field trial. Sleep, 17, 630-637.
9. Carskadon, M. A., Seidel, W. F., Greenblatt, D. J., & Dement, W. C. (1982). Daytime carryover of triazolam and flurazepam. Sleep, 5, 361-371.
10. Cirignotta, F., Mondini, S., Zucconi, M., Gerardi, R., Farolfi, A., & Lugaresi, E. (1988). Zolpidempolysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome. Pharmacology, Biochemistry & Behavior, 29, 807-809.
11. Chambers, M. J. (1992). Therapeutic issues in the behavioral treatment of insomnia. Professional Psychology: Research and Practice, 23, 131-138.
12. Chambers, M. J., & Alexander, S. D. (1992). Assessment and prediction of outcome for a brief behavioral insomnia treatment program. Journal of Behavior Therapy and Experimental Psychiatry, 23, 289-297.
13. Chilcott, L. A., & Shapiro, C. M. (1996). The socioeconomic impact of insomnia: An overview. Pharmaco-Economics, 10(suppl. 1), 1-14.
14. Cowley, G., Springen, K., Iarovici, D., & Hager, M. (1991, August 19). Sweet dreams or nightmares? Newsweek, 118, 44-49.
15. Davies, D. R. (1989). A multiple treatment approach to the group treatment of insomnia: A follow-up study. Behavioural Psychotherapy, 17, 323-331.
16. Dilsaver, S. C., Feinberg, M. & Greden, J. F. (1983). Antidepressant withdrawal symptoms treated with anticholinergic agents. American Journal of Psychiatry, 140, 249-251.
17. Dolly, F. R., & Block, A. J. (1982). Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. American Journal of Medicine, 73, 239-243.
18. Edinger, J. D., Hoelscher, T. J., Marsh, G. R., Lipper, S., & Ionescu- Pioggia, M. (1992). A cognitive-behavioral therapy for sleep-maintenance insomnia in older adults. Psychology and Aging, 7, 282-289.
19. Espie, C. A. (1991). The psychological treatment of insomnia. Chichester, England: Wiley.
20. Espie, C. A., Lindsay, W. R., & Brooks, D. N. (1988). Substituting behavioural treatment for drugs in the treatment of insomnia: An exploratory study. Journal of Behavior Therapy and Experimental Psychiatry, 19, 51-56.
21. Espie, C. A., Lindsay, W. R., Brooks, D. N, Hood, E. M., & Turvey, T. (1989). A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy, 27, 79-38.
22. Evans, S. M., Funderburk, F. R., & Griffith, R. R. (1990). Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability. Journal of Pharmacology and Experimental Therapeutics, 255, 1246-1255.
23. Finlayson, R. E., & Davis, L. J. (1994). Prescription drug dependence in the elderly population: Demographic and clinical features of 100 inpatients. Mayo Clinic Proceedings, 69, 1137-1145.
24. Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention'? Journal of American Medical Association, 262, 1479-1484.
25. Friedman, L., Bliwise, D. L., Yesavage, J. A., & Salom, S. R. (1991). A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. Journal of Gerontology, 46, P1-P8.
26. Gallup Organization. (1991). Sleep in America. Princeton, NJ: Author.
27. Goldstein, S. E., Birnbom, F., Lancee, W. J., & Darke, W. C. (1978). Comparison of oxazepam, flurazepam and chloral hydrate as hypnotic sedatives in geriatric patients. Journal of the American Geriatrics Society, 26, 366-371.
28. Guilleminauk, C., Clerk, A., Black, J., Labanowski, M., Pelayo, R., & daman, D. (1995). Nondrug treatment trials in psychophysiologic insomnia. Archives of Internal Medicine, 155, 838-844.
29. Hartmann, E., & Cravens, J. (1973a). The effects of long term administration of psychotropic drugs on human sleep: III. The effects of amitriptyline. Psychopharmacologia (Berlin), 33, 185-202.
30. Hartmann, E., & Cravens, J. (1973b). The effects of long term administration of psychotropic drugs on human sleep: V. The effects of chloral hydrate. Psychopharmacologia (Berlin), 33, 219-232.
31. Hauri, P. J. (1993). Consulting about insomnia: A method and some preliminary data. Sleep, 16, 344-350.
32. Hauri, P. J., & Wisbey, J. (1993). Can we mix behavioral therapy and hypnotics? Sleep Research, 22, 207.
33. Hauri, P. J. (1981). Treating psychophysiologic insomnia with biofeedback. Archives of General Psychiatry, 38, 752-758.
34. Hoehns, J. D., & Perry, P. J. (1993). Zolpidem: A nonbenzodiazepine hypnotic for treatment of insomnia. Clinical Pharmacology, 12, 814-828.
35. Hohagen, F., Rink, K., Kappler, C., Schramm, E., Riemann, D., Weyerer, S., & Berger, M. (1993). Prevalence and treatment of insomnia in general practice: A longitudinal study. European Archives of Psychiatry and Clinical Neuroscience, 242, 329-336.
36. Jacobs, G. D., & Benson, H., & Friedman, R. (1993). Home-based central nervous system assessment of a multifactor behavioral intervention for chronic sleep-onset insomnia. Behavior Therapy, 24, 159-174.
37. Jonas, J. M., Coleman, B. S., Sheridan, A. Q., & Kalinske, R. W. (1992). Comparative clinical profiles of triazolam versus other short-acting hypnotics. Journal of Clinical Psychiatry, 53, 19-31.
38. Kales, A., Allen, C., Scharf, M. B., & Kales, J. D. (1970). Hypnotic drugs and their effectiveness. All-night EEG studies in insomniac subjects. Archives of General Psychiatry, 28, 226-232.
39. Kales, A., Kales, J. D., Bixler, E. O., & Scharf, M. B. (1975). Effectiveness of hypnotic drugs with prolonged use: Flurazepam and pentobarbital. Clinical Pharmacology and Therapeutics, 18, 356-363.
40. Kirmil-Gray, K., Eagleston, J. R., Thoresen, C. E., & Zarcone, V. P. (1985). Brief consultation and stress management treatments for drug-dependent insomnia: Effects on sleep quality, self-efficacy, and daytime stress. Journal of Behavioral Medicine, 8, 79-99.
41. Kudo, Y., & Kurihara, M. (1990). Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: A double-blind study. Journal of Clinical Pharmacology, 30, 1041-1048.
42. Lacks, P., Bertelson, A. D., Gans, L., & Kunkel, J. (1983). The effectiveness of three behavioral treatments for different degree of sleep-onset insomnia. Behavior Therapy, 14, 593-605.
43. Lacks, P., Bertelson, A. D., Sugerman, J., & Kunkel, J. (1983). The treatment of sleep-maintenance insomnia with stimulus control techniques. Behaviour Research and Therapy, 21, 291-295.
44. Lacks, P., & Morin, C. M. (1992). Recent advances in the assessment and treatment of insomnia. Journal of Consulting and Clinical Psychology, 60, 586-594.
45. Lacks, P., & Powlishta, K. (1989). Improvement following behavioral treatment for insomnia: Clinical significance, long-term maintenance, and predictors of outcome. Behavior Therapy, 20, 117-134.
46. Langtry, H. D., & Benfield, P. (1990). Zolpidem: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs, 40, 291-313.
47. Lewin, D. S., Rosen, R. C., Goldberg, L., Rubinstein, M., LaConte, J., & Woolfolk, R. (1994, November). Drug and nondrug interactions in psychophysiological insomnia: Preliminary findings. Paper presented at the meeting of the Association for Advancement of Behavior Therapy, San Diego, CA.
48. Lichstein, K. L. (1988). Clinical relaxation strategies. New York: Wiley.
49. Lichstein, K. L., & Johnson R. S. (1993). Relaxation for insomnia and hypnotic medication use in older women. Psychology and Aging, 8, 103-111.
50. Lichstein, K. L., & Riedel, B. W. (1994). Behavioral assessment and treatment of insomnia: A review with an emphasis on clinical application. Behavior Therapy, 25, 659-688.
51. Mamdani, M. B., Hollyfield, R. L., Ravi, S. D., Dorus, W., & Borge, G. F. (1988). Sleep complaints and recidivism in alcoholics reporting use of alcohol as a hypnotic. Sleep Research, 17, 293.
52. Manning, C., Scandale, L., Manning, J., & Gengo, F. M. (1992). Central nervous system effects of meclizine and dimenhydrinate: Evidence of acute tolerance to antihistamines. Journal of Clinical Pharmacology, 32, 996-1002.
53. Mattila, M. J., Mattila, M., & Konno, K. (1986). Acute and subacute actions on human performance and interactions with diazepam or temelastine (SK. & F93944) and diphenhydramine. European Journal of Clinical Pharmacology, 31, 291-298.
54. McClusky, H. Y., Milby, J. B., Switzer, P. K., Williams, V., & Woolen, V. (1991). Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. American Journal of Psychiatry, 148, 121-126.
55. Mellinger, G. D., Balter, M. B., & Uhlenhuth, E. H. (1985). Insomnia and its treatment: Prevalence and correlates. Archives of General Psychiatry, 42, 225-232.
56. Meltzer, E. O. (1990). Performance effects of antihistamines. Journal of Allergy & Clinical Immunology, 86, 613-619.
57. Mendelson, W. B., Garnet, D., & Gillin, J. C. (1981). Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. Journal of Nervous and Mental Disease, 169, 261-264.
58. Metz, A., & Shader, R. I. (1990). Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. International Clinical Psychopharmacology, 5, 191-194.
59. Milby, J. B., Williams, V., Hall, J. N., Khuder, S., McGill, T., & Wooten, V. (1993). Effectiveness of combined triazolam-behavioral therapy for primary insomnia. American Journal of Psychiatry, 150, 1259-1260.
60. Miller, N. S., Bekin, B. M., & Gold, M. S. (1991). Alcohol and drug dependence in the elderly: Epidemiology, diagnosis, and treatment. Comprehensive Psychiatry, 32, 153-165.
61. Montgomery, I., Oswald, I., Morgan, K., & Adam, K. (1983). Trazodone enhances sleep in subjective quality but not in objective duration. British Journal of Clinical Pharmacology, 16, 139-144.
62. Morawetz, D. (1989). Behavioral self-help treatment for insomnia: A controlled evaluation. Behavior Therapy, 20, 365-379.
63. Morin, C. M. (1993). Insomnia: Psychological assessment and management. New York: Guilford Press.
64. Morin, C. M., & Azrin, N. H. (1987). Stimulus control and imagery training in treating sleep-maintenance insomnia. Journal of Consulting and Clinical Psychology, 55, 260-262.
65. Morin, C. M., & Azrin, N. H. (1988). Behavioral and cognitive treatments of geriatric insomnia. Journal of Consulting and Clinical Psychology, 56, 748-753.
66. Morin, C. M., Colecchi, C. A., Ling, W. D., & Sood, R. K. (1995). Cognitive behavior therapy to facilitate benzodiazepine discontinuation among hypnotic-dependent patients with insomnia. Behavior Therapy, 26, 733-745.
67. Morin, C. M., Colecchi, C. A., Stone, J., Sood, R. K., & Brink, D. (1995). Cognitive-behavior therapy and pharmacotherapy for insomnia: Update of a placebo-controlled clinical trial. Sleep Research, 24, 303.
68. Morin, C. M., Culbert, J. P., & Schwartz, S. M. (1994). Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. American Journal of Psychiatry, 151, 1172-1180.
69. Morin, C. M., Gaulier, B., Barry, T., & Kowatch, R. A. (1992). Patient's acceptance of psychological and pharmacological therapies for insomnia. Sleep, 15, 302-305.
70. Morin, C. M., Kowatch, R. A., Barry, T., & Walton, E. (1993). Cognitive behavior therapy for late-life insomnia. Journal of Consulting and Clinical Psychology, 61, 137-146.
71. Morin, C. M., Stone, J., McDonald, K., & Jones, S. (1994). Psychological management of insomnia: A clinical replication series with 100 patients. Behavior Therapy, 25, 291-309.
72. Morin, C. M., & Ware, C. (1996). Sleep and psychopathology. Applied and Preventive Psychology, 5, 211-224.
73. Moskowitz, H., Linnoila, M., & Roehrs, T. (1990). Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam. Journal of Clinical Psychopharmacology, 10, 44S-55S.
74. Mouret, J., Lemoine, P., Minuit, M. P., Benkelfat C., & Renardet, M. (1988). Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology, 95, S37-S43.
75. Murtagh, D. R. R., & Greenwood, K. M. (1995) Identifying effective psychological treatments for insomnia: A meta-analysis. Journal of Consulting and Clinical Psychology, 63, 79-89.
76. National Commission of Sleep Disorders Research. (1993). Wake up America: A national sleep alert. Washington, DC: Author.
77. National Institutes of Health. (1984). Drugs and insomnia: The use of medication to promote sleep. Journal of the American Medical Association, 18, 2410-2414.
78. National Institutes of Health. (1991). Consensus development conference statement: The treatment of sleep disorders of older people. Sleep, 14, 169-177.
79. National Institutes of Health. (1995). Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. Bethesda, MD: NIH Technology Assessment Conferences.
80. Nicassio, P. M., Mendlowitz, D. R., Fussell, J. J., & Petras, L. (1985). The phenomenology of the presleep state: The development of the presleep arousal scale. Behaviour Research and Therapy, 23, 263-271.
81. Nicholson, A. N., & Stone, B. M. (1986) Antihistamines: Impaired performance and the tendency to sleep. European Journal of Clinical Pharmacology, 30, 27-32.
82. Nicholson, A. N. (1979). Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man. British Journal of Clinical Pharmacology, 8, 321-24.
83. Nierenberg, A. A., Adler, L. A., Peselow, E., Zomberg, G., & Rosenthal, B. A. (1994). Trazodone for antidepressant-associated insomnia. American Journal of Psychiatry, 151, 1069-1072.
84. Pedrosi, B., Roehrs, T. A., Stepanski, E., Zorick, F., & Roth, T. (1993). Hypnotic self-administration: Comparison of methods. Sleep Research, 22, 44.
85. Pokomy, A. D. (1979). Sleep disturbances, alcohol and alcoholism: A review. In R. L. Williams & I. Karacan (Eds.), Sleep disorders (pp. 233-260). New York: Wiley.
86. Ray, W. A. (1992). Psychotropic drugs and injuries among the elderly: A review. Journal of Clinical Psychopharmacology, 12, 386-396.
87. Regestein, Q. R., & Reich, P. (1985). Agitation observed during treatment with newer hypnotic drugs. Journal of Clinical Psychiatry, 46, 280-283.
88. Rice, V. J., & Snyder, H. L. (1993). The effects of Benadryl and Hismanal on mood, physiological measures, antihistamine detection, and subjective symptoms. Aviation, Space & Environmental Medicine, 64, 717-725.
89. Richelson, E. (1994). Pharmacology of antidepressants-characteristics of the ideal drug. Mayo Clinic Proceedings, 69, 1069-1081.
90. Rickels, K., Morris, R. J., Newmann, H., Rosenfeld, H., Schiller, H., & Weinstock, R. (1983). Diphenhydramine in insomniac family practice patients: A double-blind study. Journal of Clinical Pharmacology, 23, 235-242.
91. Riedel, B. W., Lichstein, K. L., & Dwyer, W. O. (1995) Sleep compression and sleep education for older insomniacs: Self-help versus therapist guidance. Psychology and Aging, 10, 54-63.
92. Roehrs, T., Kribbs, N., Zorick, F., & Roth, T. (1986). Hypnotic residual effects of benzodiazepines with repeated administration. Sleep, 9, 309-316.
93. Roehrs, T., Vogel, G., & Roth, T. (1990). Rebound insomnia: its determinants and significance. American Journal of Medicine, 88(Suppl. 3A), 39S-42S.
94. Roth, T., & Roehrs, T. (1991). A review of the safety profiles of benzodiazepine hypnotics. Journal of Clinical Psychiatry, 52(Suppl.), 38-41.
95. Roth, T., Roehrs, T., Koshorek, G., Sicklesteel, B. A., & Zorick, F. (1987). Sedative effects of antihistamines. Journal of Allergy & Clinical Immunology, 80, 94-98.
96. Rothenberg, S. A. (1992). A pilot survey in the medical community on the use of behavioral treatments for insomnia. Sleep Research, 21, 355.
97. Sanavio, E. (1988). Pre-sleep cognitive intrusions and treatment of onset-insomnia. Behaviour Research and Therapy, 26, 451-459.
98. Sanavio, E., Vidotto, G., Bettinardi, O., Roletto, T., & Zorzi, M. (1990). Behavior therapy for DIMS: Comparison of three treatment procedures with follow-up. Behavioural Psychotherapy, 18, 151-167.
99. Scharf, M. B., & Sachais, B. A. (1990) Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. Journal of Clinical Psychiatry, 51(Suppl. 9), 13-17.
100. Schneider-Helmert, D. (1988). Why low-dose benzodiazepines-dependent insomniacs can't escape their sleeping pills. Acta Psychiatria Scandinavica, 78, 706-711.
101. Schoicket, S. L., Bertelson, A. D., & Lacks, P. (1988). Is sleep hygiene a sufficient treatment for sleep maintenance insomnia. Behavior Therapy, 19, 183-190.
102. Schorr, R. I., & Bauwens, S. F. (1992). Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. American Journal of Medicine, 93, 78-82.
103. Seidel, W. F., Cohen, S., Bliwise, N. G., & Dement, W. C. (1987). Cetirizine effects on objective measures of daytime sleepiness and performance. Annals of Allergy, 59, 58-62.
104. Shader, R. I., Greenblatt, D. J., & Balter, M. B. (1991). Appropriate use and regulatory control of benzodiazepines. Journal of Clinical Pharmacology, 31, 781-784.
105. Spielman, A. J., Saskin, P., & Thorpy, M. J. (1987). Treatment of chronic insomnia by restriction of time in bed. Sleep, 10, 45-56.
106. Stoller, M. K. (1994). Economic effects of insomnia. Clinical Therapeutics, 16, 873-897.
107. van Bemmel, A. L., Havermans, R. G., & van Diest, R. (1992). Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology, 107, 569-574.
108. Vollrath, M., Wicki, W., & Angst, J. (1989). The Zurich Study: VIII. Insomnia: Association with depression, anxiety, somatic syndromes, and course of insomnia. European Archives of Psychiatry and Clinical Neuroscience, 239, 113-124.
109. Wadworth, A. N., & McTavish, D. (1993). Zopiclone: A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs & Aging, 3, 441-459.
110. Walsh, J. K., Engelhardt, C. L., & Hartman, P. G. (1995). The direct economic cost of insomnia. In D. Nutt & W. Mendelson (Eds.), Hypnotics and anxiolytics (pp. 369-381). London: Ballière Tindall.
111. Ware, J. C., & Morewitz, J. (1991). Diagnosis and treatment of insomnia and depression. Journal of Clinical Psychiatry, 52(Suppl. 6), 55-61.
112. Ware, J. C., & Pittard, J. T. (1990). Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults. Journal of Clinical Psychiatry, 51, 18-22.
113. Weedle, P. B., Poston, J. W., & Parish, P. A. (1988). Use of hypnotic medicines by elderly people in residential homes. Journal of the Royal College General Practitioners, 38, 156-158.
114. Weintraub, M. W., Singh, S., Byrne, L., Maharaj, K., & Guttmacher, L. (1991). Consequences of the 1989 New York State triplicate prescription regulations. Journal of the American Medical Association, 266, 2392-2397.
115. Weyerer, S., & Dilling, H. (1991). Prevalence and treatment of insomnia in the community. Result from the Upper Bavarian field study. Sleep, 14, 392-398.
116. Willcox, S. M., Himmelstein, D. U., & Woolhandler, S. (1994). Inappropriate drug prescribing for the community-dwelling elderly. Journal of the American Medical Association, 272, 292-296.
117. Wysowski, D. K., & Barash, D. (1991). Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting system. Archives of Internal Medicine, 151, 2003-2008.
118. Wysowski, D. K., & Baum, C. (1991). Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Archives of Internal Medicine, 151, 1779-1783.
119. Yates, B. T. (1994). Toward the incorporation of costs, cost-effectiveness analysis, and cost-benefit analysis into clinical research. Journal of Consulting and Clinical Psychology, 62, 729-736.
120. Zorc, B. A., Larson, D. B., Lyons, J. S., & Beardsley, R. S. (1991). Expenditures for psychotropic medications in the United States in 1985. American Journal of Psychiatry, 148, 644-647.